Related Experiment Video
Updated: Jul 20, 2026
A Hydrogel Construct and Fibrin-based Glue Approach to Deliver Therapeutics in a Murine Myocardial Infarction Model.
Published on: June 14, 2015
Cardiac repair--fact or fancy?
E Leontiadis1, A Manginas, D V Cokkinos
1cokkino1@otenet.gr
Insights
Stem cell therapy offers a promising new treatment for ischemic cardiomyopathy, enhancing heart repair and function. While not fully understood, stem cells improve blood flow and cardiac performance, aiding recovery after heart attacks.
Area of Science:
- Regenerative Medicine
- Cardiology
- Stem Cell Biology
Background:
- Ischemic cardiomyopathy carries a poor prognosis despite current treatments.
- Heart transplantation is ideal but limited by donor scarcity.
- Stem cell transplantation is an emerging therapy for myocardial dysfunction.
Purpose of the Study:
- To explore the potential of autologous stem cells for cardiac repair in ischemic cardiomyopathy.
- To understand the mechanisms by which stem cells enhance myocardial repair.
- To evaluate the impact of stem cells on myocardial perfusion and contractile function.
Main Methods:
- Utilizing autologous stem cells (SCs) for transplantation.
- Investigating the effects of SCs on patients with acute myocardial infarction and chronic ischemic heart failure.
- Analyzing myocardial perfusion and contractile performance post-transplantation.
Main Results:
- Stem cells (SCs) enhance myocardial repair mechanisms.
- SCs contribute to increased myocardial perfusion and contractile performance.
- The precise mechanism of SC action is still under investigation, with theories including limited new tissue formation and secretion of cardioprotective factors.
Conclusions:
- Autologous stem cell transplantation shows potential for treating ischemic cardiomyopathy.
- SCs may improve cardiac function through paracrine effects rather than direct tissue regeneration.
- Further research is needed to fully elucidate the mechanisms and optimize stem cell therapy for heart repair.
Abstract:
Patients with ischemic cardiomyopathy have a poor prognosis despite all pharmacological, interventional and surgical treatment modalities currently applied. Heart transplantation remains the ideal treatment for this group of patients but the scarcity of donors hinders its widespread application. The autologous transplantation of stem cells (SCs) for cardiac repair is emerging as a new therapy for patients with myocardial dysfunction early after an acute infarction or ischemic cardiomyopathy. The rationale of this novel method is the enhancement of the repair mechanisms achieved by tissue-specific and circulating stem/progenitor cells. SCs assist naturally occurring myocardial repair by contributing to increased myocardial perfusion and contractile performance especially in the setting of acute myocardial infarction (AMI), but also in patients with chronic ischemic heart failure and advanced, diffuse coronary artery disease. The exact mechanism of their action has not been fully elucidated. Few studies continue to suggest a formation of few new contractile tissue. The majority if investigators believe that these cells do not persist long in the myocardium but that they secrete vascular growth and other cardioprotective factors.
Related Concept Videos
01:29Cardiomyopathy V: Interprofessional Care
01:28Cardiac Catheterization I: Pre-Procedure Overview
01:30Cardiomyopathy II: Dilated Cardiomyopathy